Stemline Therapeutics, Inc., New York, USA.
Protein Cell. 2011 Jun;2(6):456-62. doi: 10.1007/s13238-011-1063-9. Epub 2011 Jul 12.
The p53 tumor suppressor is a sequence-specific transcription factor that undergoes an abundance of post-translational modifications for its regulation and activation. Acetylation of p53 is an important reversible enzymatic process that occurs in response to DNA damage and genotoxic stress and is indispensible for p53 transcriptional activity. p53 was the first non-histone protein shown to be acetylated by histone acetyl transferases, and a number of more recent in vivo models have underscored the importance of this type of modification for p53 activity. Here, we review the current knowledge and recent findings of p53 acetylation and deacetylation and discuss the implications of these processes for the p53 pathway.
p53 肿瘤抑制因子是一种序列特异性转录因子,其调节和激活需要经历大量的翻译后修饰。p53 的乙酰化是一种重要的可逆酶促过程,发生在 DNA 损伤和遗传毒性应激响应中,对 p53 的转录活性是必不可少的。p53 是第一个被组蛋白乙酰转移酶乙酰化的非组蛋白,许多最近的体内模型强调了这种修饰对 p53 活性的重要性。在这里,我们回顾了 p53 乙酰化和去乙酰化的最新知识和发现,并讨论了这些过程对 p53 途径的影响。